A shortage of the weight-loss drug Ozempic, popular among diabetes patients, has left many unable to access it, leading to potential health risks. The surge in demand is driven by non-diabetic individuals using it for weight loss, causing supply issues. Diabetes UK calls for a ban on off-label prescribing of Ozempic during the shortage.
Key Points
Shortage of Ozempic due to increased demand from non-diabetic individuals for weight loss purposes.
Diabetes patients are struggling to access necessary medications, leading to potential health risks.
Diabetes UK calls for a ban on off-label prescribing of Ozempic during the shortage.
Pros
Ozempic has been life-changing for many diabetes patients, helping them lose weight and control blood sugar levels.
Cons
Shortage of Ozempic has left diabetes patients at risk of health complications due to unavailability of the drug.